Background Fatigue is frequent in patients with psoriasis. Though conventional drugs in
general have no effect on fatigue, biological agents have demonstrated beneficial effects in …

Background: Over the past 15 years, biologic medications have greatly advanced psoriasis
therapy. However, these medications may lose their efficacy after long-term use, a concept …

WWW. CUTIS. COM pathophysiology, to develop new metrics for its evaluation, and to
investigate therapeutic strategies to target it clinically. The following discussion provides an …

Background Fatigue is associated with various chronic inflammatory diseases, but few
studies have focused on its occurrence in psoriasis. Objectives To describe fatigue …

Objectives Fatigue is a significant issue in psoriatic arthritis. The objective was to assess the
effect of biological disease modifying antirheumatic drugs and apremilast on fatigue in …

Fatigue is a prevalent and substantial phenomenon in many patients with chronic
inflammatory diseases, often rated by patients as the most troublesome symptom and aspect …

Background A multitude of factors may influence fatigue in psoriasis and psoriatic arthritis
(PsA); however, their individual fatigue components have not been thoroughly examined …

There is a lack of validated tools to measure fatigue in patients with inflammatory skin,
neuropsychiatric, and medical disorders. The use of nonvalidated tools may compromise the …

Objective To evaluate fatigue frequency and severity among patients with psoriatic arthritis
(PsA) and assess the effect of fatigue severity on patient-reported outcome measures …

Patients have frequently described fatigue in association with chronic diseases, including
cancer and a host of neurologic, metabolic, and psychiatric diseases. Fatigue can be …